Correlation Between WUXI BIOLOGICS and ATRYS HEALTH

Can any of the company-specific risk be diversified away by investing in both WUXI BIOLOGICS and ATRYS HEALTH at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining WUXI BIOLOGICS and ATRYS HEALTH into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between WUXI BIOLOGICS UNSPADR2 and ATRYS HEALTH SA, you can compare the effects of market volatilities on WUXI BIOLOGICS and ATRYS HEALTH and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in WUXI BIOLOGICS with a short position of ATRYS HEALTH. Check out your portfolio center. Please also check ongoing floating volatility patterns of WUXI BIOLOGICS and ATRYS HEALTH.

Diversification Opportunities for WUXI BIOLOGICS and ATRYS HEALTH

0.16

Correlation Coefficient

WUXI BIOLOGICS  ATRYS HEALTH

Average diversification

The 3 months correlation between WUXI and ATRYS is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding WUXI BIOLOGICS UNSPADR2 and ATRYS HEALTH SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATRYS HEALTH SA and WUXI BIOLOGICS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on WUXI BIOLOGICS UNSPADR2 are associated (or correlated) with ATRYS HEALTH. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATRYS HEALTH SA has no effect on the direction of WUXI BIOLOGICS i.e., WUXI BIOLOGICS and ATRYS HEALTH go up and down completely randomly.

Pair Corralation between WUXI BIOLOGICS and ATRYS HEALTH

Assuming the 90 days trading horizon WUXI BIOLOGICS UNSPADR2 is expected to under-perform the ATRYS HEALTH. In addition to that, WUXI BIOLOGICS is 1.81 times more volatile than ATRYS HEALTH SA. It trades about -0.03 of its total potential returns per unit of risk. ATRYS HEALTH SA is currently generating about -0.04 per unit of volatility. If you would invest  606.00  in ATRYS HEALTH SA on September 27, 2024 and sell it today you would lose (283.00) from holding ATRYS HEALTH SA or give up 46.7% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

WUXI BIOLOGICS UNSPADR2  vs.  ATRYS HEALTH SA

WUXI BIOLOGICS UNSPADR2

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in WUXI BIOLOGICS UNSPADR2 are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, WUXI BIOLOGICS reported solid returns over the last few months and may actually be approaching a breakup point.

ATRYS HEALTH SA

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in ATRYS HEALTH SA are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, ATRYS HEALTH may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with WUXI BIOLOGICS and ATRYS HEALTH

The main advantage of trading using opposite WUXI BIOLOGICS and ATRYS HEALTH positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if WUXI BIOLOGICS position performs unexpectedly, ATRYS HEALTH can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATRYS HEALTH will offset losses from the drop in ATRYS HEALTH's long position.

The idea behind WUXI BIOLOGICS UNSPADR2 and ATRYS HEALTH SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.